LAURA O'HERN: Open Payments
NPI 1346556511 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,989 in 91 payments from 24 companies in 2025. Trend: 2023 $1,368 · 2024 $1,421 · 2025 $1,989
Food & beverage: $1,989
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $224 |
| Amgen Inc. | 21 | $220 |
| CeQur Corporation | 1 | $218 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $212 |
| Sequel Med Tech, LLC | 3 | $148 |
| Tandem Diabetes Care, Inc. | 5 | $117 |
| Lilly USA, LLC | 5 | $91 |
| ABBVIE INC. | 4 | $88 |
| Ascendis Pharma Endocrinology Inc | 5 | $87 |
| Abbott Laboratories | 4 | $78 |
Products named: CeQur Simplicity, Kerendia, Ozempic, TWIIST, t:slim X2 Insulin Pump with Control-IQ, EVENITY, TEPEZZA, FREESTYLE LIBRE 3.
Industry payments across AR — which companies pay providers there.
